Neuralink, the brain-technology company co-founded by Elon Musk, has announced the launch of the PRIME Study, a clinical trial for its fully implantable, wireless brain-computer interface (BCI).
Dec 12 (Reuters) - The U.S. Securities and Exchange Commission (SEC) this week has reopened an investigation into Elon Musk's brain-chip startup Neuralink, according to a letter, opens new tab ...
Dec 5 (Reuters) - An animal testing laboratory at Elon Musk's Neuralink brain technology company was found to have "objectionable conditions or practices" by the Food and Drug Administration ...
Neuralink is therefore launching a new feasibility trial, aimed at extending control of the brain-computer interface using the N1 implant to an experimental assistive robotic arm.